for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Westlaw News

Drugmaker Almirall settles kickback allegations for $6.6 million

Spanish drugmaker Almirall has agreed to pay $6.6 million to resolve claims that its U.S. unit paid kickbacks to incentivize doctors to prescribe its dermatology products, the U.S. Justice Department and lawyers for a whistleblower said on Wednesday.

The settlements will resolve allegations first raised by a former sales representative who claimed the company used kickbacks to promote its drugs Monodox, Cordran and Acticlate in a whistleblower lawsuit filed in federal court in Philadelphia.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/30S3yca

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up